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Diagnosis of Dry Eye
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Abstract
Dry eye is a multifactorial disease and hence single test cannot diagnose dry eye. 
Diagnosis of dry eye needs careful assessment of the symptoms along with battery 
of investigations. Many questionnaires have been developed to assess the symptoms 
of dry eye disease (DED). Some of the important questionnaires are Ocular Surface 
Disease Index (OSDI), Dry Eye Questionnaire (DEQ-5), Impact of Dry Eye on 
Everyday Living (IDEEL), National Eye Institute’s Visual Function Questionnaire 
(NEI VFQ-25) and Dry Eye-Related Quality-of-Life Score (DEQS). Investigations 
for dry eye mainly target on the tear secretion, tear clearance, tear volume, tear 
film stability, tear evaporation, ocular surface damage, lipid layer of the tear film, 
chemical properties of the tear film and inflammation of the ocular surface. There 
are many investigations that target on the above parameters and helps in accurate 
diagnosis of Dry eye disease (DED).
Keywords: Dry eye disease, Ocular surface index (OSDI), Schirmers test,  
Phenol red test, Fluorescein
1. Introduction
1.1 Definition
Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEW) II 
amended the definition of dry eye into “Dry eye is a multifactorial disease of the 
ocular surface characterized by a loss of homeostasis of the tear film, and accompa-
nied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular 
surface inflammation and damage, and neurosensory abnormalities play etiological 
roles.” [1]. So, basically patients are not required to present with a particular set of 
symptoms to be diagnosed as dry eye disease (DED) but rather homeostasis of the 
tear film is more emphasized upon.
1.2 Classification
DED is classified into two main categories by TFOS DEW II. The two main types 
are the following-
1. Aqueous deficiency – It occurs due to deficient tear production.
2. Evaporative – Meibomian gland disease (MGD) lead to deficiency of lipid layer 
which ultimately leads to excessive evaporation of tears [1].
Dry Eye
2
The diagnosis of DED is not only based upon investigations but rather it depends 
on both the investigations and signs and symptoms of DED.
2. Questionnaires
Numerous questionnaires have been developed till date to study dry eye symp-
toms for many purposes such as diagnosis and quantification of DED, to study 
epidemiology of the disease, to assess effects of the treatment and its impact on the 
quality of life. The questionnaires are as follows-.
2.1 Ocular Surface Disease Index (OSDI)
It is a questionnaire consisting 12 questions, developed by the Outcome Research 
Group at Allergan which was designed for quick assessment of the symptoms of 
DED and their impact on vision related problems such as visual disturbance (poor 
vision or blurred vision) and visual function problems (difficulty in watching TV. 
working on a computer, driving at night and reading) [2].
The response to all the questions is graded on a scale of 0 to 4 -
a. none of the time
b. some of the time
c. half of the time
d. most of the time
e. all of the time




sum allof scores for questions answered 100
OSDI





A randomized study was performed on 68 patients admitted in ophthalmol-
ogy Polyclinic of the Dumlupinar University from December 2005 to April 2006. 
Patients of 18 years and above were included in the study. The history taking and 
OSDI calculation was done by the same physician. Then after the routine ophthal-
mic assessment, the Schirmer test and TBUT were performed by another physician. 
The correlation analysis was done between Schirmer test, TBUT and OSDI scores. 
The patients were divided into 3 groups according to the OSDI scores and they are 
as follows-
• Group 1 had patients with low OSDI score of 0–20 points
• Group 2 had patients with moderate OSDI score of 21–45 points
• Group 3 had patients with high OSDI score of 46–100 points [3].
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The result showed there was a statistically significant difference between 
TBUT test scores of patients with low and high OSDI scores (p = .043), there was 
no significant difference between Schirmer test scores of the three groups. They 
concluded that although there is no internationally accepted criterion for the 
diagnosis of DED as of now, the OSDI is a standardized questionnaire to  evaluate 
symptoms, and can easily be performed and used to support the diagnosis of 
DED [3].
2.2 Dry Eye Questionnaire (DEQ-5)
It is a questionnaire in which 4 dimensions are used to measure a series of 
symptoms. The 4 dimensions are -.
a. Frequency of watery eyes.
b. Degree of bother.
c. Late day intensity of discomfort and dryness (PM intensity).
d. Morning intensity of discomfort and dryness (AM intensity).
DEQ-5 scores of ≥ 6 establish suspicion of DED and indicates further clinical 
testing and of ≥ 12 establishes a suspicion of Sjogren syndrome (SS) [4].
A study reported that 10% of patients with non-Sjogren syndrome DED and 
30% of patients with Sjogren syndrome complained of impaired vision while few 
of the other studies reported that 42% and 80% of patients with Sjogren syndrome 
experienced impaired vision [5–7].
It is believed that open-eye conditions might affect symptom progression as 
visual problems generally increase in intensity over the day [8].
2.3 Impact of Dry Eye on Everyday Living (IDEEL)
The questionnaire has 2 items related to visual problems.
a. Blurry vision
b. Sensitivity to light, glare, and/or wind.
Statistically significant differences were observed between various patients od 
DED with varying level of severity and in responses to the IDEEL questionnaire 
scores [9].
2.4 National Eye Institute’s Visual Function Questionnaire (NEI VFQ-25)
NEI VFQ-25 is a questionnaire that checks visual function by focusing on seven 
visual domains including general vision, near vision, distance vision, peripheral 
vision, color vision, driving difficulties and ocular pain. DED patients have poor 
NEI VFQ-25 scores for the subscales of general health, general vision, ocular pain, 
short distance vision activities, long distance vision activities, vision-related social 
function, vision-related mental health, vision-related role difficulties, vision-
related dependency, and driving [10, 11].
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2.5 Dry Eye-Related Quality-of-Life Score (DEQS)
This questionnaire developed in Japan. It has shown strong correlations with 4 
subscales of the NEI VFQ-25 namely Ocular Pain, Near Vision, Distance Vision, and 
Mental Health [12].
2.6 Computer-vision symptom scale (CVSS17)
It is a Rasch linear scale containing 17 items. It explores 15 different symptoms 
of computer-related visual and ocular symptoms and is considered very valuable in 
computer related ocular morbidities. The CVSS17 includes a broad range of symp-
toms such as photophobia and excessive blinking [13].
2.7 McMonnies’ Questionnaire (MQ )
It is a screening instruments for DED that reported sensitivity to be varying between 
87–98% and specificity between 87% and 97% [14, 15]. It consists of 12 questions. 
Every question has polytomous response options that vary in number and type [16].
2.8 Ocular Comfort Index (OCI and OCI-C)
It was developed by Johnson and Murphy in 2007. It allows the quick assessment 
of the ocular comfort and grading the severity of DED. It uses Rasch analysis to 
produce estimates on a linear scale. It contains 15 items [17].
2.9 Symptoms Assessment in Dry Eye (SANDE)
It is based on 100 mm horizontal linear visual analog scale that quantifies both 
severity and frequency of dry eye symptoms. It consists of 2 questions [18].
2.10 Standard Patient Evaluation of Eye Dryness (SPEED)
It is based on both frequency and severity of the symptoms of the DED. It 
was designed to track diurnal and long-term symptom changes over a period of 
3 months. The total score was calculated by adding the scores from both the fre-
quency and severity parts of the questionnaire.
The symptoms inquired by the SPEED questionnaire include dryness or grit-
tiness or scratchiness, soreness or irritation, burning sensation or watering and 
ocular fatigue reported and scored as sometimes – 1, often – 2 and constant – 3 and 
whether these symptoms pose no problems −0, were tolerable - 1, uncomfortable - 
2, bothersome - 3, or intolerable −4 [19].
There are 3 more questionnaires which were developed to diagnose DED in the 
contact lens wearers –.
2.11 Contact Lens Dry Eye Questionnaire (CLDEQ )
It was developed by Begley [20]. It was used to investigate the frequency and 
severity of the symptoms of DED in contact lens wearers. It is quite similar to DEQ 
but the only difference is that patients here are using contact lens. It consists of 36 
items [21]. It divides symptoms into nine subscales -
• Dryness
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• Irritation and soreness
• Grittiness or scratchiness
• Burning sensation
• Foreign body sensation
• Itching
• Photophobia
2.12 8-Item Contact Lens Dry Eye Questionnaire (CLDEQ-8)
The CLDEQ-8 is a short form of the CLDEQ questionnaire that was designed to 
describe symptoms among contact lens wearers [21].
2.13 Contact lens impact on Quality of life (CLIQ )
It is a questionnaire containing 28 items. It is based on Rasch analysis and shows 
good validity and reliability. Boer suggested that the psychometric properties of 
CLIQ were of high quality [22].
It is important to emphasize that these Questionnaires are not diagnostic tool, 
however can give a good clinical assessment of the problem. It acts as preliminary 
tool of assessment and is meant for screening purposes. Proper diagnosis requires a 
battery of additional tests. These above questionnaires act as adjunct to the clinical 
tests and cannot replace them in any form.
3. Diagnosis and ancillary testing
3.1 Aim
Investigations of DED are set with following goals -.
a. To confirm the clinical diagnosis of DED.
b. To quantify the DED.
Various tests have been devised to diagnose DED but no test can singly give you 
a diagnosis of DED. The correct way to diagnose DED it to correlate between the 
signs and symptoms of patients and the investigations planned.
3.2 Parameters to be measured






d. Tear film stability.
e. Tear evaporation.
f. Ocular surface damage.
g. Tear film chemical properties.
h. Lipid layer.
3.3 Investigations
3.3.1 To test the tear secretion and tear volume
3.3.1.1 Schirmer test
It is a test to quantify the tear production.
It is done with a blotting paper strip of 5 X 35 mm which is popularly known as 
Whatman filter paper number 41.
Method of application- It is folded 5 mm from the inner end which is rounded 
and placed in the lower fornix at the junction of middle and outer one-third and 
kept for 5 minutes. Touching the cornea or lashes should be avoided. Eyes should be 
gently closed during the procedures [23].
The normal tear production varies between 0.5 to 0.67 ml of tears/day and that 
wets more than 15 mm of the strip.
The Schirmer test are basically of 3 types but the most important amongst them 
are the first two.
• Schirmer’s test I –It is done without the use of topical anesthesia and measures 
maximum basic plus reflex tear secretion.
• Schirmer’s test II - It is done with the help of anesthesia. A drop of anesthesia is 
put in the eye, excess is wiped out with the help of filter paper. Then Whatman 
strip is placed same as in Schirmer test I. It measures only the basal tear 
secretion.
• Schirmer’s test III - The patient is advised to look directly in the sun and it is 
done to know about the reflex tear secretion. It is dangerous and of no  
diagnostic value, so not used.
The cut-off values for diagnosis have been proposed as ≤5 mm/5 min to 
≤10 mm/5 min with 77–85% sensitivity and 70–83% specificity [23].
This test lacks repeatability and shows variable results, so a single test should 
not be used to diagnosis rather a series of abnormal results in Schirmer’s test raise a 
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3.3.1.1.1 Strip meniscometry
A variation of the above test is available now-a-days, which is done by dipping a 
strip into tear meniscus for 5 seconds. 25 mm polyethylene terephthalate is used to 
make the strip and it is covered with a urethane-based material [24]. The value  
≤ 4 mm raises suspicion of DED. When used alone it has a sensitivity and  specificity 
of 84% and 58% respectively and when combined with Tear film break-up time test 
the sensitivity is reduced to 81% but the specificity increases to 99% [25].
3.3.1.1.2 1-minute Schirmer test
It was proposed by Nelson to decrease the ocular discomfort and save time by 
decreasing the time of performing the test from 5 minutes to 1 minute [26]. The 
cut-off value was set to be 6 mm. Bawazeer and Hodge et al. in 2003 concluded 
that the 1-minute Schirmer test with anesthesia highly correlates with the 5-minute 
Schirmer test with anesthesia [27]. In cases of severe dry eye, a value of ≤ 5.5 mm 
in a 5-minute Schirmer test highly correlates with 2 mm in a 1-minute Schirmer 
test while in cases of mild to moderate dry eye a value of 5–10 mm in a 5- minute 
Schirmer test corresponds with 3–6 mm in a 1-minute Schirmer test.
3.3.1.2 Phenol red thread test (PRT)
It uses a thin cotton thread impregnated with pH-sensitive dye “phenol red”. When 
the dye is dry, the thread is of yellow color, but when the dry is moistened by tears, the 
thread turns red (as the tears has slightly alkaline pH between 7 and 8) [28].
Method of application- the folded end of the thread is hooked over the lower 
eyelid margin in the temporal one-third if the eyelid for 15 seconds.
It has few advantages, as it is small in dimension so less chance of reflex tearing 
and the minimal amount of dye on thread decreases the chances of reflex tearing 
[29, 30]. It suggests that the reading of PRT is indirect and realistic measure of the 
tear volume in resting phase [31, 32]. But despite these potential advantages it is 
rarely used in clinical practice as it is manufactured only in few countries which 
makes their supply costly.
A cut-off value of 20 mm is used for differentiation of DED with and without 
aqueous deficiency [33]. Sensitivity and specificity of a cut-off value of 10 mm are 
25% and 93% respectively [34].
Doughty et al. concluded that there is no statistically significant difference in the 
PRT performed with open or closed eyes [35].
3.3.2 To test the tear clearance
3.3.2.1 Fluorescein clearance test
Method- 5 μl of 2% fluorescein dye is instilled in the eyes. One set of Schirmer 
papers are inserted for each 10-minute interval for 30 minutes. The amount of strip 
becoming wet and the disappearance of the dye were recorded. Nasal stimulation is 
done using a cotton tip along with the last strip to induce reflex tear secretion.
It is used to measure basal tears, reflex tears and tear clearance all at the 
same time.
A cut-off value of ≥ 3 mm at the 10-minute interval suggests normal tear 




It has many advantages such as it is inexpensive, easy to perform, availability of 
the materials used is adequate. The disadvantages are same as in standard Schirmer 
test. Jordan and Baum et al. in 1980 reported that the above disadvantages cannot be 
suppressed by use of topical anesthesia [37].
3.3.2.2 Tear function index (TFI)
Method- The procedure is similar to the Schirmer test with anesthesia, but it 
uses 10-μl of 0.5% fluorescein.
Fluorescein is instilled into the lower conjunctival fornix and after 5 min-
utes of instillation the length of the wetted portion of the strip is measured 
and the intensity of the staining of dye is compared to the standard strips. The 
rate at which the color of the fluorescein dye fades is used to determine the 




Values of Schirmer test with anesthesia
=  (2)
Kaye et al. proposed a variation of TFI by suggesting use of prepared strip 
containing 1.3 μl of 0.5% fluorescein. They reported that 10 μl of fluorescein use 
increases the volume of tear and it may also act as a stimulant. This in turn limits the 
applicability of the TFI test [38].
3.3.2.3 Fluorophotometry
Fluorophotometry is useful clinical tool, because an increased corneal uptake of 
fluorescein demonstrates subtle damage to the corneal epithelium. In humans, mea-
surements of the penetration of fluorescein across the corneal epithelium can be 
used in diagnosing or monitoring dry eye disease. It is an excellent test but the need 
of the machine itself makes it a costly test so it not much used in clinical practice.
3.3.3 To test the tear volume
3.3.3.1 Tear meniscus assessment by Meniscometry
Tear meniscus height (TMH), curvature (TMR), and cross-sectional area 
(TMA) are used in clinical practice widely and have good accuracy rate and cor-
relate well with other tests of DED [39, 40]. However, they are very much operated 
dependent. They have other drawbacks such as dependency on time from blink, 
fluorescein instillation. It can be influenced by the temperature, humidity, air veloc-
ity, illumination and location of measurement along the lid margin.
Now-a-days portable digital meniscometry with application software being 
installed in the iPod touch are being used. They have good reproducibility, good 
correlation with both the conventional video and Optical coherence tomography 
(OCT) meniscometry and it detects tear meniscus changed after the instillation of 
artificial tears.
At present, OCT meniscometry studies parameters such as upper and lower 
TMH, TMA, TMR and tear meniscus depth most commonly. Intra-observer and 
inter-observer repeatability are good with spectral-domain OCT meniscometry. All 
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these measurements in the OCT meniscometry are machine dependent and can be 
influenced by the following conditions - conjunctivochalasis, LIPCOF, disorders of 
lid margin congruity, and apposition between the lid and ocular surface [41–44]. 
But it has many advantages such as it is non-invasive and image is taken rapidly and 
its simple but analysis of the image may take time [45]. It is an excellent but costly 
tool to test tear volume.
3.3.4 To test the tear film stability
3.3.4.1 Tear film break-up time (TBUT)
This is the time interval between the last complete blink and the appearance of 
the first randomly distributed dry spot [46, 47]. It is the most commonly done test 
for assessing the tear film stability.
It can either be done with or without fluorescein 2% dye. When done with dye it 
is known as Fluorescein break-up time (FBUT). The dye enhances the visibility of 
tear film but it also reduces the stability of the tear film and therefore the measure-
ment may not be accurate [48, 49].
Method- Fluorescein 2% is instilled in the eye. It can be instilled in varying 
volume and concentrations either by impregnated strips or micropipette. A stan-
dardized method is to be followed every time and instructions are given to naturally 
blink thrice than stop blinking until instructed again [50].
A cut-off of < 10 seconds is used to diagnose DED. In patients of Sjogren syn-
drome, the sensitivity and specificity of the test have been reported to be 72.2% and 
61.6%, respectively [7].
3.3.4.2 Non- invasive tear break-up time (NIBUT)
Tear film stability is believed to be affected by various factors such as tempera-
ture, fluorescein dye, humidity, air circulation so NIBUT is more reliable than the 
other tests.
Method –
• Placido disk -It can be measured with the help of a Placido disk images 
reflected over the anterior corneal surface with corneal topography sys-
tems [51].
• Keratography - Automated assessment is done with instruments having 
specific software such as keratography which detects and finds the location of 
tear film break-up over time [52, 53].
• High speed video keratography – The variance of the number of radial rings is 
estimated form center of the center image [54–56].
• Interferometry – It measures the time between the last blink and the appear-
ance of first discontinuity in the lipid layer of the tear film. Recently instru-
ments measuring the thickness of the lipid layer have also been developed 
[57–61].
A cut-off of < 10 seconds is used to diagnose DED. The sensitivity and speci-
ficity of the NIBUT is reported to vary according to the technique used, with 




When the tear film is evaporated it leaves the ocular surface cool [64]. Infrared 
thermography is used to measure the absolute temperature and the spatial and 
temporal changes in temperature during the inter-blink period. It can be used as an 
index of tear film stability.
Purslow and Wolffsohn reported that the ocular surface temperature measured 
by infrared thermography is related to the tear film [65]. The literature has given 
many evidences that indicates the cooling rate of the ocular surface is faster in 
individuals with DED than in normal eyes, which is assumed to be as a result of a 
greater rate of tear film evaporation [64, 66–68].
3.3.4.4 Osmolarity variability
Osmolarity in the patients of DED varies which in turn affects tear film stability. 
The inter-eye variability of osmolarity in patients of DED is greater than normal 
people [69–70]. As the severity of DED increases, this inter-eye difference of 
osmolarity also increases [71].
3.3.4.5 Tear evaporation rate
It is used as an indicator of tear film stability [72]. Lipid layer is necessary to 
prevent tear film evaporation. An absent and non-confluent lipid layer of tear film 
is thought to have association with a 4-fold increase in evaporation rate in normal 
patients and in patients of keratoconjunctivitis sicca, tear evaporation rate is 
thought to be increased by 2-fold [73, 74].
Method: Different techniques are used to measure tear film evaporation such as 
vapor pressure gradient and the velocity of increase in relative humidity (resistance 
hygrometry) [74–77].
3.3.5 To test the tear evaporation
Goto, Shimazaki et al. in 2002 reported the importance of evaluation of tear 
evaporation in dry eye assessment [78].
It is a non-invasive procedure and aim at assessing tear dynamics, differentiates 
the subcategories of DED and evaluating the treatment [79–84]. There are three 
methods for the measurement:
3.3.5.1 The evaporimeter system
The two humidity sensors are placed at different heights from the ocular surface 
and they are used to evaluate tear evaporation rates [79].
3.3.5.2 The closed-chamber system
At a given ambient humidity in a closed chamber, the velocity of the humidity 
increases and it is used to estimate the tear evaporation rate [80–82].
3.3.5.3 The ventilated chamber system
The evaporimeter consists of an eyecup in the form of a ventilated chamber 
which tightly covers the eye [85].
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3.3.6 To test the ocular surface damage
3.3.6.1 Ocular surface staining
Vital and supra-vital stains are used to demonstrate the damaged epithelium. 
Staining occurs over cornea and conjunctiva in different fashion.
Cornea is stained in manner such that lower part (lower one-third) is stained 
more than upper part and nasal part stained more than temporal part.
Bulbar conjunctiva is stained nasally and temporally in a wedge-shaped 
zone [86]. It is a commonly used and cost -effective test.
The dyes used in the procedure are as follows:
• Fluorescein – 1% or 2% commercial preparation is used clinically for the ocular 
surface staining. It stains the surface when there is a disruption of cell junc-
tions. It stains corneal epithelial damage better than conjunctiva. At physi-
ologic pH, fluorescein is highly water soluble and hence poorly penetrates the 
lipid layer and doesn’t stain normal cornea. It is orange in color and fluoresces 
green when excited by blue light.
Yokoi and Kinoshita in 1998 reported that conjunctival damage precedes that 
of the cornea and is more severe.
Method – Either it is instilled in form of a drop or impregnated strip. Excess 
dye is washed off if drop is instilled. Best results are obtained when viewed 
through a yellow barrier filter (such as Kodak Wratten 12 absorption filter) 
plus the standard blue exciter filter of the slit lamp [86].
In the absence of yellow filter, the conjunctival stain is seen poorly.
• Rose Bengal (RB) – It is available as 1% commercial preparation.
Method – Firstly, topical anesthesia is instilled in the eye to limit stinging with 
the dye. The dye is then instilled in the lower conjunctival sac. Excess dye is 
washed off with normal saline.
The staining is dose-dependent, the more the dose of dye the more is the stain-
ing. Rose Bengal stains ocular surface epithelial cells that are unprotected by 
mucin or glycocalyx, as well as dead or degenerated cells [87].
However, RB staining has many disadvantages as well which limits its association 
with dry eye. Schein et al. in 1997 reported that it stains in asymptomatic patients 
as well and does not correlate with the subjective symptoms [88]. RB causes 
staining of the Marx’s line i.e., the mucocutaneous junctions of the lid margin. 
And thus, does not seem to have sufficient sensitivity and specificity [89].
• Lissamine Green – It is a synthetic acidic dye that stains similarly to RB. But 
it is not stringent to the eyes. Staining is dose- dependent. Staining should be 
checked at a proper time. It should neither be hasty nor be delayed as evaluat-
ing the staining too quickly does not allow the staining pattern to develop and 
if the evaluation is delayed the stain pattern starts fading. Ideally it should be 
checked between 1 and 4 minutes after staining [90].
• SCORING SYSTEM –
Most commonly 3 methods are used to grade the ocular surface staining –
• Van Bijsterveld system – This system was developed in 1969. The whole ocular 
surface is divided into 3 zones – cornea, nasal bulbar conjunctiva and temporal 
Dry Eye
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bulbar conjunctiva. Each zone is the scaled from 0 to 3 where 0 indicates no 
staining and 3 indicates confluent staining. The maximum possible score 
in 9 [91].
• NEI/Industry Workshop guidelines – This system was developed in 1995. The 
cornea is divided into 5 sectors namely central, superior, inferior, nasal and 
temporal, each of them is scored from 0 to 3. The maximum score is 15. Both 
the nasal and temporal conjunctiva is divided into 3 areas namely superior 
paralimbal area, inferior paralimbal area and peripheral area, each of which 
is scored from 0 to 3 with a maximum score of 9 for both nasal and temporal 
conjunctiva [92].
• Oxford scheme – This scheme was developed by Bron in 2003. There is a chart 
with series of panels labeled from A-E in order of severity- absent, minimal, 
mild, moderate and severe [93].
Recently, Miyata and coauthors described a new method for grading  
fluorescein staining in superficial punctate keratitis (SPK). Both the area and 
density of SPK were graded. The area was graded from A0 to A3 and the den-
sity was graded from D0 to D3 and then these two were combined in a single 
index [94].
3.3.6.2 Impression cytology
It is used to diagnose diseases like DED, limbal stem-cell deficiency, ocular 
surface neoplasia, and specific viral infections [95]. In patients of DED, it is used 
to study squamous metaplasia and goblet cell density of the conjunctiva for the 
diagnosis and monitoring of the disease [96].
Method - Cells from the first to third most superficial layers of the epithelium 
are removed by application of cellulose acetate filters or bio-pore membranes, and 
the cells can be subsequently analyzed by various methods including microscopy, 
immunocytochemistry, immunoblotting analysis, polymerase chain reaction, and 
flow cytometry, depending on the aim of the investigation [97].
Several squamous metaplasia grading systems by Nelson, Tseng and Blades are 
used to analyze the conjunctival impression cytology [98–100].
3.3.6.3 Lid Parallel Conjunctival Folds (LIPCOF)
These are the folds in bulbar conjunctiva in the lateral and lower quadrant which 
are parallel to the lower lid margin. They represent mild stage of conjuntivochalasis 
but clinically they are slightly different [101].
The tear meniscus height measurements may be underestimated due to 
LIPCOF [44].
3.3.6.4 In-vivo confocal microscopy (IVCM)
It is a non-invasive technique to evaluate the signs of ocular surface damage in 
DED patients at cellular level. The signs such as decreased corneal (apex and lower 
periphery), and conjunctival epithelial cell density, conjunctival squamous meta-
plasia (increased mean individual epithelial cell area, decreased nucleocytoplasmic 
ratio and goblet cell density), and corneal nerve changes (decreased sub-basal nerve 
density, increased tortuosity and increased number of bead-like formations) are 
evaluated [102–106].
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3.3.6.5 Ocular surface sensitivity
The palpebral conjunctival sensitivity appears to be more critical than corneal sen-
sitivity when assessing DED [107]. The instruments like Cochet-Bonnet or non-contact 
air-jet esthesiometers have been employed to evaluate ocular surface sensitivity.
3.3.7 To test the lipid layer of the tear film
The precorneal lipid layer assessment is done with the help of tear film 
interferometry.
The lid margin lipid layer assessment is done with the help of meibometry [108].
The meibomian gland assessment is done with the help of meibography [109].
3.3.7.1 Tear film interferometry
It is a non-invasive method that is used to visualize the translucent surface of the 
lipid layer of the tear film. McDonald in 1968 was first to analyze the tear interfer-
ence images [110].
3.3.8 To test the chemical properties of the tear film
3.3.8.1 Tear film osmolarity
Interferon gamma is significantly increased in amount if the tear film on the 
ocular surface becomes hyperosmolar but other cytokines such as Th1, Th2 and 
Th17 have no significant increase in amount [111].
It has the highest correlation to disease severity of clinical DED tests [112].
Various literatures have proposed many cut-off values for DED from 
305 mOsm/L to 316 mOsm/L [113], with reported sensitivities and specificities 
ranging from 64–91% and 78–96% respectively [113–117].
3.3.8.2 Tear film ferning
When tear film is dried on a glass plate, it causes ferning. There are few pre 
requisites for the process such as slow crystal growth rate, low solution viscosity 
and low impurity levels to permit free-solute diffusion. Seven to ten minutes under 
normal room temperature of 20 to 26°C and room humidity of (RH up to 50%) has 
been recommended [118].
The crystallization begins with the formation of a nucleus, due to the supersatu-
ration of ions with solvent evaporation at the peripheral edge of the drop. Normal 
crystals are formed when the sample solute is able to diffuse into areas with a lower 
solute concentration [118].
Electrolytes may play a role in ferning as hyperosmolarity has been found to 
result in deteriorated ferns [113, 119].
Tear ferning changes with contact lens wear have been found to have a moder-
ately high sensitivity (78.4%) and specificity (78.4%) for predicting contact lens 
tolerance in a clinical setting [120].
Healthy tear samples produce compact, dense ferning patterns, while in dry eye 
samples, the pattern is fragmented or absent.
3.3.8.3 Biochemical analysis of the tear composition




3.3.9 To test the inflammation of the ocular surface
Inflammation, although not specific, but is a recognized as one of the compo-
nent of the pathophysiological mechanism of DED.
3.3.9.1 Ocular or conjunctival redness
This is the most common and consistent sign of ocular surface inflammation 
[121–123]. It can easily be detected with a pen torch or on slit lamp examina-
tion. It is not specific to DED and can occur in any disease with inflammation, 
for example, in response to chemical injury, infective conjunctivitis or allergic 
conjunctivitis.
3.3.9.2 Matrix metalloproteinases
They are secreted into the tears of a DED patients [72, 124–126]. It destroys the 
tight junctions of the ocular surface epithelium which in turn leads to loss of ocular 
surface barrier function. This assay produces a dichotomous outcome, with levels 
above 40 ng/ml producing a positive result, and is non-specific to the source of 
ocular surface inflammation.
3.3.9.3 Cytokines and chemokines
They reflect the level of epithelial disease. Elevation of Th1 and Th17 subclasses 
of cytokines suggest involvement of particular T lymphocyte differentiation path-
ways in the disease. Elevation of tear Th2 cytokines, on the other hand, may suggest 
a more allergic-based disease, although recent evidence suggests various aspects 
of T cell Th1, Th2 and Th17 exist across aqueous deficient, evaporative and mixed 
forms of DED, with a propensity towards Th1 type T cell responses as a more global 
indicator of DED [127].
3.3.9.4 Ocular sursface immune markers
The most commonly used ocular surface immune marker is HLA-DR expression, 
a Class-II MHC antigen, which indicates a loss of the normally immune-suppressed 
environment of the ocular surface.
Although the authors found increased expression of HLA-DR associated with 
increased clinical severity of DED [128], but in comparison with other studies the 
normal levels of HLA-DR expression showed high variability ranging from 5–54% 
and the study also suggested the weak correlation of HLA-DR and traditional 
clinical signs of DED [129]. Other relevant markers of apoptosis include CAM-1, 
CD14+, CD8+ and CD4+ cells [130, 131].
3.3.9.5 In vivo confocal imaging
Corneal sub-epithelial and stromal IVCM signs of inflammation have been 
hypothesized and studied in DED [132, 133].
4. Clinical protocol for dry eye 
The recommended order and clinical practice procedural recommendations are 
as follows:
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• Symptoms - DEQ-5 or OSDI are self-administered. The result is considered 
positive if the DEQ-5 score is 6 or if OSDI score is 13.
• Tear breakup time
a. NIBUT - The cut-off for a positive finding can be as low as 2.7 seconds for 
automated algorithms, and up to 10 seconds for subjective observation 
techniques.
b. FBUT - A positive finding has been reported to be a value < 10 seconds.
• Osmolarity - A positive result is considered to be 308 mOsm/L with the 
currently available device in either eye [69, 71] or an interocular difference 
>8 mOsm/L [112].
• Ocular surface staining – by lissamine green and fluorescein dye.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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